Consensus Labcorp Holdings Inc.

Stocks

LH

US5049221055

Healthcare Facilities & Services

Market Closed - NYSE 16:00:02 2026-09-04 EDT			5-day change	1st Jan Change
326.89 ^USD	-1.39%		-2.45%	+30.30%

09-02	Ultrahuman Healthcare Pvt Ltd. announced that it has received INR 6.62 billion in funding from Qualcomm Ventures LLC, Blume Venture Advisors Private Limited, Labcorp Holdings Inc., Alpha Wave Global, LP, Nexus Venture Partners, Alteria Capital Advisors LLP and other investors	CI
09-01	Argus Adjusts Price Target on Labcorp Holdings to $370 From $310, Keeps Buy Rating	MT

Evolution of the Average Target: Labcorp Holdings Inc.

Evolution of the Target Price: Labcorp Holdings Inc.

Changes in Analyst Recommendations: Labcorp Holdings Inc.

cfdf746ea.aH9AHgkoGKGh1j3x3YMcWQ-vEDYtJwetQxDobcGtMYc.Py0XSlseX8DgjgnEp_tdAFnWZXN4fn71JXWcHfL1UrMjEA4vP0RxlvS9CQ~a6b25aca4a5e7ae2cf2e72053f995472

Analysts' recommendations: Labcorp Holdings Inc.

09-01	Argus Adjusts Price Target on Labcorp Holdings to $370 From $310, Keeps Buy Rating	MT
08-24	HSBC Adjusts Price Target on Labcorp Holdings to $330 From $270	MT
08-24	Analyst recommendations: Kimberly-Clark, Palantir, Snap, Crowdstrike, Accenture…
08-04	Piper Sandler Adjusts Price Target on Labcorp Holdings to $309 From $300, Maintains Neutral Rating	MT
07-31	Deutsche Bank Adjusts Labcorp Price Target to $306 From $276, Maintains Hold Rating	MT
07-31	Rothschild & Co Redburn Adjusts Price Target on Labcorp Holdings to $385 From $325, Maintains Buy Rating	MT
07-31	Jefferies Adjusts Price Target on Labcorp Holdings to $355 From $320, Maintains Buy Rating	MT
07-31	Morgan Stanley Adjusts Price Target on Labcorp Holdings to $338 From $308, Maintains Overweight Rating	MT
07-31	Barclays Adjusts Price Target on Labcorp to $320 From $290, Maintains Equalweight Rating	MT
07-31	Leerink Partners Adjusts Price Target on Labcorp Holdings to $350 From $340, Maintains Outperform Rating	MT
07-31	Baird Adjusts Price Target on Labcorp Holdings to $352 From $338, Maintains Outperform Rating	MT
07-31	Truist Raises Price Target on Labcorp Holdings to $350 From $320, Keeps Buy Rating	MT
07-30	Barclays Raises Labcorp Price Target to $320 From $290, Maintains Equalweight Rating	MT
07-30	Labcorp Q2 Adjusted EPS, Revenue Rise; Raises 2026 Guidance	MT
07-13	Baird Adjusts Labcorp Price Target to $338 From $335, Maintains Outperform Rating	MT
07-07	Evercore ISI Adjusts Price Target on Labcorp to $315 From $300	MT
05-18	Baird Adjusts Price Target on Labcorp Holdings to $335 From $334, Maintains Outperform Rating	MT
05-01	Baird Adjusts Labcorp Price Target to $334 From $332	MT
05-01	Leerink Partners Adjusts Labcorp Price Target to $340 From $347	MT
04-30	Leerink Partners Lowers Labcorp Price Target to $340 From $347	MT
04-14	Baird Adjusts Price Target on Labcorp Holdings to $332 From $327, Maintains Outperform Rating	MT
04-14	Leerink Partners Adjusts Labcorp PT to $347 From $342, Maintains Outperform Rating	MT
04-02	HSBC Adjusts Price Target on Labcorp Holdings to $270 From $260, Maintains Hold Rating	MT
03-09	Baird Adjusts Price Target on Labcorp to $327 From $325	MT
03-03	Baird Adjusts Price Target on Labcorp Holdings to $325 From $326, Maintains Outperform Rating	MT

More recommendations

Medical & Diagnostic Laboratories

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	LABCORP HOLDINGS INC.					+4.47%
	NATERA, INC.					+3.01%
	SONIC HEALTHCARE LIMITED					+15.21%
	RADNET, INC.					+28.37%
	DR. LAL PATHLABS LIMITED					+3.82%
	GENEDX HOLDINGS CORP.					+5.18%
	NEOGENOMICS, INC.					+13.48%
	FLEURY S.A.					-9.06%
	GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.					+16.8%
	VIJAYA DIAGNOSTIC CENTRE LIMITED					+2.48%
	Average					+8.38%
	Weighted average by Cap.					+6.01%